Global Real-time PCR Instrumentsand Reagents Market Growth (Status and Outlook) 2023-2029

Global Real-time PCR Instrumentsand Reagents Market Growth (Status and Outlook) 2023-2029

LPI (LP Information)' newest research report, the “Real-time PCR Instrumentsand Reagents Industry Forecast” looks at past sales and reviews total world Real-time PCR Instrumentsand Reagents sales in 2022, providing a comprehensive analysis by region and market sector of projected Real-time PCR Instrumentsand Reagents sales for 2023 through 2029. With Real-time PCR Instrumentsand Reagents sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Real-time PCR Instrumentsand Reagents industry.
This Insight Report provides a comprehensive analysis of the global Real-time PCR Instrumentsand Reagents landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Real-time PCR Instrumentsand Reagents portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Real-time PCR Instrumentsand Reagents market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Real-time PCR Instrumentsand Reagents and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Real-time PCR Instrumentsand Reagents.
The global Real-time PCR Instrumentsand Reagents market size is projected to grow from US$ 4187.9 million in 2022 to US$ 7070.9 million in 2029; it is expected to grow at a CAGR of 7.8% from 2023 to 2029.
The main manufacturers of Real-time PCR Instruments and Reagents are Thermo Fisher Scientific, Roche and DaAn Gene, etc. The top five manufacturers account for about 30% of the share. China is the largest market with around 45% share, followed by North America and Europe with over 20% and 15% share. Reagent is the largest segment with a roughly 70% share. Infectious Disease are the largest application, accounting for about 80% of the share.
This report presents a comprehensive overview, market shares, and growth opportunities of Real-time PCR Instrumentsand Reagents market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Reagent
Instrument
Segmentation by application
Infectious Disease
Prenatal and Postnatal Care
Cancer Screening and Treatment
Organ Transplant
Individual Identification
Agriculture
Customs Quarantine
Food Safety
Forensic
Research and Development
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
Roche
DaAn Gene
Sansure Biotech
QIAGEN
Bio-Rad
Biosynex
Cepheid
Hangzhou Bloer Technology
Liferiver Bio-Tech
Xi'an Tianlong Science and Technology
Bioperfectus Technologies
BGI Group
Agilent Technologies
Hybribio
Shanghai Biogerm Medical
Shanghai Hongshi Medical Technology
Suzhou Molarray
Merck
Analytik Jena
Takara
Meridian Life Science
Promega Corporation

Please note: The report will take approximately 2 business days to prepare and deliver.